Moran Wealth Management »

Tg Therapeutics shares owned by Moran Wealth Management

Quarter-by-quarter ownership of Tg Therapeutics (TGTX) shares owned by Moran Wealth Management from 13F filings

Historical chart of Moran Wealth Management investment in Tg Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tg Therapeutics held by Moran Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tg Therapeutics by Moran Wealth Management

Quarter filed Position value Share count Share price at filing
2023-06-30 $380k 15k 24.84

More positions owned by Moran Wealth Management

Broadcom (AVGO)
Parker-Hannifin Corporation (PH)
NVIDIA Corporation (NVDA)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Microsoft Corporation (MSFT)
Trane Technologies SHS (TT)
Progressive Corporation (PGR)
Cadence Design Systems (CDNS)
Garmin SHS (GRMN)
Howmet Aerospace (HWM)
Williams-Sonoma (WSM)
Ameriprise Financial (AMP)
Caterpillar (CAT)
EOG Resources (EOG)
JPMorgan Chase & Co. (JPM)

View all positions for Moran Wealth Management

Top funds holding Tg Therapeutics

BlackRock
Vanguard Group
State Street Corporation
ClearBridge Advisors
Soleus Capital Management
Geode Capital Management
Susquehanna International
Congress Asset Management
Jane Street
Citadel Advisors
Pictet Asset Management Holding SA
Hood River Capital Management
Goldman Sachs Group
Northern Trust
Charles Schwab Investment Management

View all funds holding Tg Therapeutics